- Advertisement -

Find a job

Subscribe for free

All things Pharma


Changes to legislation, NHS reforms and how pharma can support healthcare going forward.


Triumphs and tribulations: a forecast for 2022

As we move into an uncertain 2022, Wilmington Healthcare’s Oli Hudson picks out three underlying themes that are likely to influence the way industry...

Adapting for success: Understanding commercial optimisation

"Commercial optimisation can be transformative for pharmaceutical companies’ bottom line"
- Advertisement -

NHS receives extra £5.4 billion to support COVID-19 response over next 6 months

The Prime Minister and Health and Social Care Secretary Sajid Javid have announced that the NHS will receive an extra £5.4 billion over the...


- Advertisement -
- Advertisement -

Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace

As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting from these reforms that...

Setting the scene: sarcoma diagnosis and treatment

July marks Sarcoma Awareness Month and the 10th anniversary of the bone and soft...

Genetic variants identified that impact immune cells’ functioning

Genetic variants have been identified that impact immune cells' functioning. Certain genetic variants that...

New transatlantic cancer research partnership

The two largest funders of cancer research in the world are set to make...


Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription